Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG)
Latest Information Update: 16 Aug 2021
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Blood coagulation disorders; COVID-19 respiratory infection
- Focus Therapeutic Use
- Acronyms RAPID COVID COAG
- 11 Aug 2021 Status changed from recruiting to completed.
- 10 Feb 2021 New trial record